Danantara Indonesia will invest $20 billion in a wide range of projects from metal processing to artificial intelligence, ...

Conference call to discuss new data presented for duvakitug (Anti-TL1A) positive Phase 2b results at the 20th Annual Congress of the European ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 88 tables and 75 figures, this 196-page report ?Asia Pacific Active Pharmaceutical Ingredients (API) Market 2022-2032 by ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

JAKARTA – Indonesia has questioned the fairness of the Paris climate agreement after the US announced its withdrawal from the pact, even as green groups in Indonesia look to China to take the ...

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions.

Indonesia’s parliament has approved the creation of a new sovereign investment fund in order to manage some of the country’s most important state-owned enterprises and generate capital for ...